HLB Co., Ltd. (KOSDAQ:028300)
South Korea · Delayed Price · Currency is KRW 47,600
-2,900 (-5.74%)
Nov 7, 2025, 3:30 PM KST
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 6.25 trillion as of November 10, 2025. Its market cap has decreased by -29.82% in one year.
Market Cap
6.25T
Enterprise Value
6.39T
Revenue
75.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
47,600.00
Market Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 6.25T, an increase of 46,298.71%. That is a compound annual growth rate of 43.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 6.42T | -33.00% |
| Dec 30, 2024 | 9.59T | 46.53% |
| Dec 28, 2023 | 6.54T | 98.02% |
| Dec 29, 2022 | 3.30T | -10.84% |
| Dec 30, 2021 | 3.71T | -24.18% |
| Dec 30, 2020 | 4.89T | -0.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.09T |
| ALTEOGEN | 28.24T |
| SK Biopharmaceuticals | 9.08T |
| Yuhan | 8.62T |
| Peptron | 6.67T |
| ABL Bio | 5.58T |
| Hanmi Pharm. | 5.57T |